Clinical Trial

A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective, multicenter, single arm observational study is to evaluate the efficacy and safety of the BFCA regimen in ≥ 40 years old SAA patients undergoing haplo-HSCT.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-07
notable Primary completion pushed: 2026-12 -> 2027-12 2026-07-07
minor Completion pushed: 2028-12-30 -> 2029-12-30 2026-07-07
Trial Details
NCT Number NCT07586735
Lead Sponsor Peking University People's Hospital
Conditions Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
Enrollment 64 participants
Start Date 2026-06
Primary Completion 2027-12 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-06